OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacological Reviews is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Seventy-Five Years of Interactions: The Department of Physiology and Pharmacology at Karolinska Institutet and Pharmacological Reviews	667
Table of Contents	446
Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review	268
INNOVATIVE THERAPEUTICS FOR RENOPROTECTION: WHERE WE ARE	232
Neurobiological Mechanisms of Nicotine Reward and Aversion	151
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes	118
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics	105
L-Type Calcium Channel Blockers: A Potential Novel Therapeutic Approach to Drug Dependence	101
The Nitrogen Mustards	97
Editorial Board	93
Review of Natural Language Processing in Pharmacology	90
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapies	89
Table of Contents	88
Table of Contents	87
Carbonic anhydrase inhibitors: “Old” drugs with new potential in unexpected areas	86
Table of Contents	81
Optical Approaches for Investigating Neuromodulation and G Protein–Coupled Receptor Signaling	80
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes	76
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins	74
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023	72
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review	70
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer	63
The Hippo pathway: Organ size control and beyond	62
Table of Contents	61
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases	59

Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response	59
G Protein-Coupled Receptor Pharmacology—Insights from Mass Spectrometry	59
Asthma Therapeutics: Past, Present, and Future	59
Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism	56
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications	55
Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease	53
Nonhormonal Male Contraceptive Development—Strategies for Progress	52
Sulfotransferase 2B1b, Sterol Sulfonation, and Disease	51
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?	47
Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood	47
Corrigendum to “International Union of Basic and Clinical Pharmacology. CXIX. Fundamental insights and clinical relevance regarding the carnitine palmitoyltransferase family of enzymes” [Pharmacologic	46
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy	44
Neurobiology of the incubation of drug craving: An update	44
Dopamine, Immunity, and Disease	42
Editorial Board	41
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease	40